Global Urology Drugs Market Professional Survey Report 2019

Table of Contents

Executive Summary

1 Industry Overview of Urology Drugs

• 1.1 Definition of Urology Drugs
• 1.2 Urology Drugs Segment by Type
  • 1.2.1 Global Urology Drugs Production Growth Rate Comparison by Types (2014-2025)
  • 1.2.2 Α (alpha)-blockers
  • 1.2.3 5 α-reductase inhibitors
• 1.3 Urology Drugs Segment by Applications
  • 1.3.1 Global Urology Drugs Consumption Comparison by Applications (2014-2025)
  • 1.3.2 Hospital
  • 1.3.3 Clinic
  • 1.3.4 Others
• 1.4 Global Urology Drugs Overall Market
  • 1.4.1 Global Urology Drugs Revenue (2014-2025)
  • 1.4.2 Global Urology Drugs Production (2014-2025)
  • 1.4.3 North America Urology Drugs Status and Prospect (2014-2025)
  • 1.4.4 Europe Urology Drugs Status and Prospect (2014-2025)
  • 1.4.5 China Urology Drugs Status and Prospect (2014-2025)
  • 1.4.6 Japan Urology Drugs Status and Prospect (2014-2025)
  • 1.4.7 Southeast Asia Urology Drugs Status and Prospect (2014-2025)
  • 1.4.8 India Urology Drugs Status and Prospect (2014-2025)

2 Manufacturing Cost Structure Analysis

• 2.1 Raw Material and Suppliers
• 2.2 Manufacturing Cost Structure Analysis of Urology Drugs
• 2.3 Manufacturing Process Analysis of Urology Drugs
• 2.4 Industry Chain Structure of Urology Drugs

3 Development and Manufacturing Plants Analysis of Urology Drugs

• 3.1 Capacity and Commercial Production Date
• 3.2 Global Urology Drugs Manufacturing Plants Distribution
• 3.3 Major Manufacturers Technology Source and Market Position of Urology Drugs
• 3.4 Recent Development and Expansion Plans

4 Key Figures of Major Manufacturers

• 4.1 Urology Drugs Production and Capacity Analysis
• 4.2 Urology Drugs Revenue Analysis
• 4.3 Urology Drugs Price Analysis
• 4.4 Market Concentration Degree

5 Urology Drugs Regional Market Analysis

• 5.1 Urology Drugs Production by Regions
  • 5.1.1 Global Urology Drugs Production by Regions
  • 5.1.2 Global Urology Drugs Revenue by Regions
• 5.2 Urology Drugs Consumption by Regions
• 5.3 North America Urology Drugs Market Analysis
  • 5.3.1 North America Urology Drugs Production
  • 5.3.2 North America Urology Drugs Revenue
  • 5.3.3 Key Manufacturers in North America
  • 5.3.4 North America Urology Drugs Import and Export
• 5.4 Europe Urology Drugs Market Analysis
  • 5.4.1 Europe Urology Drugs Production
  • 5.4.2 Europe Urology Drugs Revenue
  • 5.4.3 Key Manufacturers in Europe
  • 5.4.4 Europe Urology Drugs Import and Export
• 5.5 China Urology Drugs Market Analysis
  • 5.5.1 China Urology Drugs Production
  • 5.5.2 China Urology Drugs Revenue
  • 5.5.3 Key Manufacturers in China
  • 5.5.4 China Urology Drugs Import and Export
• 5.6 Japan Urology Drugs Market Analysis
  • 5.6.1 Japan Urology Drugs Production
  • 5.6.2 Japan Urology Drugs Revenue
  • 5.6.3 Key Manufacturers in Japan
  • 5.6.4 Japan Urology Drugs Import and Export
• 5.7 Southeast Asia Urology Drugs Market Analysis
  • 5.7.1 Southeast Asia Urology Drugs Production
  • 5.7.2 Southeast Asia Urology Drugs Revenue
  • 5.7.3 Key Manufacturers in Southeast Asia
  • 5.7.4 Southeast Asia Urology Drugs Import and Export
• 5.8 India Urology Drugs Market Analysis
  • 5.8.1 India Urology Drugs Production
  • 5.8.2 India Urology Drugs Revenue
  • 5.8.3 Key Manufacturers in India
  • 5.8.4 India Urology Drugs Import and Export

6 Urology Drugs Segment Market Analysis (by Type)

• 6.1 Global Urology Drugs Production by Type
• 6.2 Global Urology Drugs Revenue by Type
• 6.3 Urology Drugs Price by Type

7 Urology Drugs Segment Market Analysis (by Application)

• 7.1 Global Urology Drugs Consumption by Application
• 7.2 Global Urology Drugs Consumption Market Share by Application (2014-2019)

8 Urology Drugs Major Manufacturers Analysis

• 8.1 Astellas
  • 8.1.1 Astellas Urology Drugs Production Sites and Area Served
  • 8.1.2 Astellas Product Introduction, Application and Specification
  • 8.1.3 Astellas Urology Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.1.4 Main Business and Markets Served
• 8.2 Endo
  • 8.2.1 Endo Urology Drugs Production Sites and Area Served
  • 8.2.2 Endo Product Introduction, Application and Specification
  • 8.2.3 Endo Urology Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.2.4 Main Business and Markets Served
• 8.3 GP Pharm
  • 8.3.1 GP Pharm Urology Drugs Production Sites and Area Served
  • 8.3.2 GP Pharm Product Introduction, Application and Specification
  • 8.3.3 GP Pharm Urology Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.3.4 Main Business and Markets Served
• 8.4 Tolmar
  • 8.4.1 Tolmar Urology Drugs Production Sites and Area Served
  • 8.4.2 Tolmar Product Introduction, Application and Specification
  • 8.4.3 Tolmar Urology Drugs Production, Revenue, Ex-factory Price and Gross Margin (2014-2019)
  • 8.4.4 Main Business and Markets Served

9 Development Trend of Analysis of Urology Drugs Market

• 9.1 Global Urology Drugs Market Trend Analysis
  • 9.1.1 Global Urology Drugs Market Size (Volume and Value) Forecast 2019-2025
• 9.2 Urology Drugs Regional Market Trend
  • 9.2.1 North America Urology Drugs Forecast 2019-2025
  • 9.2.2 Europe Urology Drugs Forecast 2019-2025
  • 9.2.3 China Urology Drugs Forecast 2019-2025
  • 9.2.4 Japan Urology Drugs Forecast 2019-2025
  • 9.2.5 Southeast Asia Urology Drugs Forecast 2019-2025
  • 9.2.6 India Urology Drugs Forecast 2019-2025
• 9.3 Urology Drugs Market Trend (Product Type)
• 9.4 Urology Drugs Market Trend (Application)
• 10.1 Marketing Channel
  • 10.1.1 Direct Marketing
  • 10.1.2 Indirect Marketing
• 10.3 Urology Drugs Customers

11 Market Dynamics

• 11.1 Market Trends
• 11.2 Opportunities
• 11.3 Market Drivers
• 11.4 Challenges
• 11.5 Influence Factors

12 Conclusion

13 Appendix

• 13.1 Methodology/Research Approach
  • 13.1.1 Research Programs/Design
  • 13.1.2 Market Size Estimation
  • 13.1.3 Market Breakdown and Data Triangulation
• 13.2 Data Source
  • 13.2.1 Secondary Sources
  • 13.2.2 Primary Sources
• 13.3 Author List